Matt Hrapchak
Boehringer Ingelheim (Brazil)(BR)Boehringer Ingelheim (Japan)(JP)Boehringer Ingelheim (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, HIV/AIDS drug development and treatment, Chemical Reactions and Isotopes, Hepatitis C virus research, Biochemical and Molecular Research
Most-Cited Works
- → A Superior Method for the Reduction of Secondary Phosphine Oxides(2005)138 cited
- → Design and Synthesis of Dipeptide Nitriles as Reversible and Potent Cathepsin S Inhibitors(2002)83 cited
- → Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β: Part I: Hit-to-Lead Strategies(2006)67 cited
- → A Practical Approach to the Synthesis of 2,4-Disubstituted Oxazoles from Amino Acids(2002)65 cited
- → Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK)(2003)48 cited
- → The discovery of thienopyridine analogues as potent IκB kinase β inhibitors. Part II(2009)32 cited
- → Synthesis of empagliflozin, a novel and selective sodium‐glucose co‐transporter‐2 inhibitor, labeled with carbon‐14 and carbon‐13